coronary heart disease
Conditions
Interventions
Western conventional treatment + Chinese medicine treatment group (Part 2):None
Western conventional treatment group (part two):None
Coronary artery disease observation group (part one):None
Coronary heart disease chest pain pre hospital registration observation group:None
Sponsors
Wangjing hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Part one: 1. Respondents aged 30-70 years; 2. Meet the diagnostic criteria for each population; 3. Sign the Informed Consent Form and voluntarily participating in this study. Part two: 1. Age range from 30 to 70 years old, male or female not limited; 2. Meet the diagnostic criteria for stable angina pectoris; 3. Meet the diagnostic criteria of traditional Chinese medicine for chest obstruction, qi deficiency, and blood stasis type; 4. Sign the "Informed Consent" and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: Part one: 1. Patients with mental illness; 2. Individuals with severe liver and kidney dysfunction; 3. Participants in other studies; 4. Unable to cooperate with researchers; 5. Incomplete information affects the judgement. Part two: 1. History of myocardial infarction or unstable angina within 3 months, or coronary revascularization; 2. Combination of other cardiac diseases, neurosis, menopausal syndrome, hyperthyroidism, cervical rheumatism and other diseases that may cause chest pain; 3. Active liver disease, or with persistent elevation of serum transaminases of unknown cause, or upper limit of normal reference value of ALT; 4. Severe abnormal renal function; 5. Serious primary diseases such as combined respiratory, haematological or malignant neoplasm; 6. Pregnant or lactating women or women of childbearing age with childbearing requirements; 7. Patients with psychiatric disorders, or cognitive impairment; 8. Those with expected poor compliance and unable to follow up regularly; 9. Other conditions deemed by the investigator to exist that make participation in the study inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seattle angina questionnaire scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of cardiovascular events;Changes in TCM evidence scores;Anti-ischaemic drug applications;Haemodynamic indicators;Blood lipid indicators; | — |
Countries
China
Contacts
Public ContactChenhao Zhang
Wangjing Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed